CFO4Life Group’s Cencora COR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$411K Sell
1,308
-2
-0.2% -$698 0.06% 140
2025
Q4
$442K Sell
1,310
-3
-0.2% -$1.02K 0.06% 137
2025
Q3
$410K Buy
1,313
+5
+0.4% +$1.47K 0.06% 142
2025
Q2
$392K Buy
1,308
+2
+0.2% +$576 0.06% 137
2025
Q1
$363K Buy
1,306
+13
+1% +$3.27K 0.06% 139
2024
Q4
$291K Buy
1,293
+87
+7% +$20.5K 0.05% 157
2024
Q3
$271K Buy
+1,206
New +$280K 0.05% 169
2024
Q2
Sell
-1,185
Closed -$288K 209
2024
Q1
$288K Buy
1,185
+116
+11% +$26.7K 0.05% 153
2023
Q4
$220K Buy
+1,069
New +$209K 0.04% 162
2023
Q3
Sell
-1,061
Closed -$204K 174
2023
Q2
$204K Buy
+1,061
New +$184K 0.04% 153
2022
Q2
Sell
-1,557
Closed -$241K 151
2022
Q1
$241K Buy
1,557
+5
+0.3% +$708 0.05% 134
2021
Q4
$206K Buy
+1,552
New +$191K 0.04% 148
2018
Q2
Sell
-2,406
Closed -$207K 128
2018
Q1
$207K Hold
2,406
0.18% 88
2017
Q4
$221K Buy
+2,406
New +$199K 0.17% 95
2017
Q3
Sell
-2,406
Closed -$227K 102
2017
Q2
$227K Hold
2,406
0.21% 77
2017
Q1
$213K Buy
+2,406
New +$211K 0.19% 88

Other funds holding COR

CFO4Life Group's COR Position: Q1 2026 in Review

CFO4Life Group reduced its Cencora (COR) stake by 0.15% in Q1 2026, selling an estimated $698 and leaving 1,308 shares worth $411K. The position accounts for 0.06% of the portfolio, ranked #140.

CFO4Life Group first reported a position in COR in Q1 2017 and has held it in 16 quarters since. The position peaked at $442K in Q4 2025. 1,426 funds tracked by Wall St. Rank hold COR as of Q1 2026.

  • CFO4Life Group held 1,308 shares of Cencora worth $411K as of Q1 2026.
  • CFO4Life Group sold 2 Cencora shares in Q1 2026, an estimated $698.
  • Cencora made up 0.06% of CFO4Life Group's portfolio in Q1 2026, its #140 holding.
  • CFO4Life Group first reported a position in Cencora in Q1 2017 and has held it in 16 quarters since.
  • CFO4Life Group's Cencora position peaked at $442K in Q4 2025.
  • 1,426 funds tracked by Wall St. Rank held Cencora as of Q1 2026.

Based on CFO4Life Group's 13F filing for Q1 2026, filed 11 May 2026.